TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lipocine ( (LPCN) ) has shared an update.
Lipocine announced its participation in the H.C. Wainwright 27th Annual Global Investor Conference held from September 8-10, 2025, in New York City. The event provided Lipocine an opportunity to present and meet with investors, potentially impacting its market visibility and investor relations.
The most recent analyst rating on (LPCN) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Lipocine stock, see the LPCN Stock Forecast page.
Spark’s Take on LPCN Stock
According to Spark, TipRanks’ AI Analyst, LPCN is a Neutral.
Lipocine’s overall stock score is driven by a strong balance sheet and positive corporate developments, which are offset by ongoing profitability challenges and bearish technical indicators. The company’s active pipeline and strategic initiatives offer potential upside, but financial and valuation concerns remain significant.
To see Spark’s full report on LPCN stock, click here.
More about Lipocine
Average Trading Volume: 38,728
Technical Sentiment Signal: Sell
Current Market Cap: $15.66M
For a thorough assessment of LPCN stock, go to TipRanks’ Stock Analysis page.